DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 141 filers reported holding DIPLOMAT PHARMACY INC in Q4 2019. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $91,000 | -18.0% | 22,721 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $111,000 | -18.4% | 22,721 | +1.8% | 0.00% | -50.0% |
| Q2 2019 | $136,000 | +7.1% | 22,321 | +1.8% | 0.00% | 0.0% |
| Q1 2019 | $127,000 | -56.2% | 21,921 | +1.8% | 0.00% | -60.0% |
| Q4 2018 | $290,000 | – | 21,525 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
| STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
| S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
| Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
| Investors Research Corp | 89,727 | $546,000 | 0.28% |
| Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
| FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
| EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |